JP2022118264A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022118264A5 JP2022118264A5 JP2022102647A JP2022102647A JP2022118264A5 JP 2022118264 A5 JP2022118264 A5 JP 2022118264A5 JP 2022102647 A JP2022102647 A JP 2022102647A JP 2022102647 A JP2022102647 A JP 2022102647A JP 2022118264 A5 JP2022118264 A5 JP 2022118264A5
- Authority
- JP
- Japan
- Prior art keywords
- fecal
- excretion
- promoting
- lipid excretion
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (6)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022102647A JP2022118264A (en) | 2017-08-10 | 2022-06-27 | Lipid eliminant |
| JP2024077813A JP2024092065A (en) | 2017-08-10 | 2024-05-13 | Lipid eliminant |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017156129A JP7535838B2 (en) | 2017-08-10 | 2017-08-10 | Lipid excretion promoter |
| JP2022102647A JP2022118264A (en) | 2017-08-10 | 2022-06-27 | Lipid eliminant |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017156129A Division JP7535838B2 (en) | 2017-08-10 | 2017-08-10 | Lipid excretion promoter |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024077813A Division JP2024092065A (en) | 2017-08-10 | 2024-05-13 | Lipid eliminant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022118264A JP2022118264A (en) | 2022-08-12 |
| JP2022118264A5 true JP2022118264A5 (en) | 2023-03-08 |
Family
ID=61832837
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017156129A Active JP7535838B2 (en) | 2017-08-10 | 2017-08-10 | Lipid excretion promoter |
| JP2022102647A Pending JP2022118264A (en) | 2017-08-10 | 2022-06-27 | Lipid eliminant |
| JP2024077813A Pending JP2024092065A (en) | 2017-08-10 | 2024-05-13 | Lipid eliminant |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017156129A Active JP7535838B2 (en) | 2017-08-10 | 2017-08-10 | Lipid excretion promoter |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024077813A Pending JP2024092065A (en) | 2017-08-10 | 2024-05-13 | Lipid eliminant |
Country Status (1)
| Country | Link |
|---|---|
| JP (3) | JP7535838B2 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002275077A (en) | 2001-01-11 | 2002-09-25 | Kanebo Ltd | Lipase inhibitor |
| TW200612902A (en) | 2004-05-13 | 2006-05-01 | Kaneka Corp | Inhibiting agents for lipase or cholesterol esterase, and absorption suppressing agents for neutral fat, cholesterol, or cholesterol ester |
| JP2017039675A (en) * | 2015-08-21 | 2017-02-23 | 興和株式会社 | Lipase inhibitor |
-
2017
- 2017-08-10 JP JP2017156129A patent/JP7535838B2/en active Active
-
2022
- 2022-06-27 JP JP2022102647A patent/JP2022118264A/en active Pending
-
2024
- 2024-05-13 JP JP2024077813A patent/JP2024092065A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Drewes et al. | Recent findings on natural products with erectile-dysfunction activity | |
| CN103735838B (en) | One breeding kidney health care medicinal liquor for tonifying kidney and preparation method thereof | |
| Ansari | ‘Ilāj bi’l-Tadbīr (regimenal therapy): a core mode of Unani treatment | |
| Ring | History of allergy in antiquity | |
| CN103182064A (en) | Medicine for treating cough due to wind-cold evil and preparation method thereof | |
| Doyle | Adolf Hitler’s medical care | |
| CN100518775C (en) | Medicine composition for treating cough and asthma and preparation thereof | |
| JP2022118264A5 (en) | ||
| CN105267906A (en) | Compound chocolate Chinese herbal composition for treating and improving menstrual syndrome of females | |
| Qader et al. | Better Prevention of COVID-19 and Infectious Diseases in Islamic Culture: A Study of Islam and Health | |
| Vallejo et al. | Human urine-based therapeutics in Spain from the early 20th century to the present: a historical literature overview and a present-day case study | |
| Ornsteen | Chronic generalized fibromyositis | |
| Gunarathna et al. | Effect of Panchatikta Ghrita and Gandhakadi Taila in the Management of Kitibha (Psoriasis)-A Case study | |
| Mukherjee et al. | Ayurveda—Translational approaches towards validation as sustainable healthcare practices | |
| CN102058764B (en) | Medicinal composition for treating acquired immune deficiency syndrome (AIDS) and application thereof | |
| Varghese et al. | Unconventional substances of abuse: Scorpions and lizards | |
| CN103721019B (en) | A kind of Chinese medicine composition improving rheumatoid arthritis | |
| RU2767879C1 (en) | Method for correcting metabolic disorders in perimenopausal women | |
| Khan et al. | A PROPHYLACTIC STUDY ON UNANI DRUGS IN COVID-19 AT CRIUM, LUCKNOW | |
| CN105056161A (en) | Traditional Chinese medicine composition for treating anxiety disorder | |
| Ebong | Ethnobotanicals: A Panacea for Primary Health Care Delivery | |
| Choi | Incentives to encourage peer review | |
| Latif | Huqna (Enema & Basti) Therapy | |
| CN105688038A (en) | Tetanus mixture and preparation method thereof | |
| Chandran | A Comparative Study to Assess The Effectiveness of Constitutional Medicine VS Ocimum Canum in Hyperuricemia |